Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone ...

Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

After nearly 11 years of living with Hodgkin lymphoma, my sister Kathleen passed away peacefully at 39, leaving me to ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...

Oluwole is an associate professor of medicine in the Division of Hematology Oncology, Department of Medicine, at Vanderbilt University Medical Center, where he specializes in the treatment of ...

Daniel Jernazian, a two-time cancer survivor, shares how sports, advocacy and meeting his idol shaped his journey through ...

Dr. Dinesh Raj Neupane is a public health pharmacist. He obtained his degree in Public Health at Tribhuvan University, Institute of Medicine, Maharajgunj Medical Campus, in Kathmandu.

Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can ...

I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life ...

Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...